Shuwen Liu Selected Research

3-hydroxyphthalic anhydride

1/2020	3-Hydroxyphthalic Anhydride-Modified Chicken Ovalbumin as a Potential Candidate Inhibits SARS-CoV-2 Infection by Disrupting the Interaction of Spike Protein With Host ACE2 Receptor.
3/2013	3-Hydroxyphthalic anhydride-modified human serum albumin as a microbicide candidate inhibits HIV infection by blocking viral entry.
4/2011	Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuwen Liu Research Topics

Disease

71	Infections 08/2022 - 01/2004
28	Neoplasms (Cancer) 02/2022 - 02/2013
24	Virus Diseases (Viral Diseases) 09/2021 - 03/2005
23	Human Influenza (Influenza) 01/2022 - 04/2010
12	Inflammation (Inflammations) 01/2021 - 11/2012
8	HIV Infections (HIV Infection) 01/2022 - 08/2002
8	Acquired Immunodeficiency Syndrome (AIDS) 10/2021 - 08/2002
7	COVID-19 08/2022 - 01/2020
5	Esophageal Neoplasms (Esophageal Cancer) 03/2016 - 03/2011
4	Shock 01/2022 - 01/2019
4	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2019
4	Proteinuria 01/2018 - 06/2002
4	Severe Acute Respiratory Syndrome 07/2005 - 11/2004
3	Pneumonia (Pneumonitis) 01/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 06/2021 - 10/2019
3	Hypoxia (Hypoxemia) 12/2020 - 06/2015
3	Communicable Diseases (Infectious Diseases) 12/2020 - 03/2018
3	IGA Glomerulonephritis (IGA Nephropathy) 04/2004 - 06/2002
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2012
2	Dengue (Dengue Fever) 09/2021 - 02/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2021 - 01/2019
2	Rheumatoid Arthritis 01/2021 - 01/2017
2	Asthma (Bronchial Asthma) 01/2021 - 05/2012
2	Body Weight (Weight, Body) 07/2020 - 12/2017
2	Edema (Dropsy) 03/2020 - 10/2013
2	Sepsis (Septicemia) 01/2019 - 04/2014
2	Osteolysis 01/2017 - 05/2016

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 08/2022 - 06/2002
24	Antiviral Agents (Antivirals)IBA 08/2022 - 03/2004
20	Pharmaceutical PreparationsIBA 09/2021 - 06/2002
18	Peptides (Polypeptides)IBA 01/2022 - 01/2004
13	Amyloid (Amyloid Fibrils)IBA 01/2020 - 11/2012
11	VaccinesIBA 08/2022 - 03/2005
8	Glycoproteins (Glycoprotein)IBA 11/2021 - 11/2004
8	CytokinesIBA 10/2021 - 12/2017
8	Anti-Infective Agents (Microbicides)IBA 09/2021 - 05/2005
8	Hemagglutinins (Hemagglutinin)IBA 04/2021 - 01/2012
6	Messenger RNA (mRNA)IBA 09/2021 - 01/2017
5	Therapeutic UsesIBA 01/2022 - 06/2002
5	LipopolysaccharidesIBA 01/2022 - 10/2013
5	OvalbuminIBA 01/2021 - 04/2011
5	Cisplatin (Platino)FDA LinkGeneric 03/2016 - 03/2011
4	LipidsIBA 11/2021 - 06/2002
4	obatoclaxIBA 04/2019 - 12/2013
4	CreatinineIBA 03/2014 - 06/2002
3	NucleosidesIBA 11/2021 - 09/2012
3	AntigensIBA 06/2021 - 05/2013
3	RNA (Ribonucleic Acid)IBA 01/2021 - 05/2013
3	InterferonsIBA 11/2020 - 06/2012
3	CarrageenanIBA 03/2020 - 10/2013
3	3-hydroxyphthalic anhydrideIBA 01/2020 - 04/2011
3	ADS J1IBA 01/2019 - 05/2014
3	3- fluoro- N- (2- (1- piperidinyl)ethyl)- 5- (trifluoromethyl)benzamideIBA 12/2017 - 06/2011
3	Celecoxib (Celebrex)FDA Link 01/2016 - 03/2011
3	AntibodiesIBA 05/2013 - 11/2004
2	Contrast MediaIBA 02/2022 - 11/2021
2	gadolinium oxide (gadolinia)IBA 02/2022 - 01/2020
2	carbopol 940 (sodium polyacrylate)IBA 02/2022 - 01/2020
2	EndonucleasesIBA 01/2022 - 03/2020
2	Biological ProductsIBA 01/2022 - 01/2012
2	ResveratrolIBA 01/2022 - 01/2020
2	Liver X ReceptorsIBA 01/2022 - 01/2021
2	SMU-Z1IBA 10/2021 - 05/2019
2	Sirtuin 1IBA 09/2021 - 06/2015
2	HydrogelsIBA 06/2021 - 09/2020
2	GoldIBA 06/2021 - 03/2019
2	SARS-CoV-2 spike proteinIBA 05/2021 - 04/2020
2	AmidesIBA 04/2021 - 01/2019
2	SaponinsIBA 04/2021 - 01/2019
2	TriterpenesIBA 04/2021 - 01/2019
2	Neuraminidase (Sialidase)IBA 04/2021 - 08/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 04/2021 - 12/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2021 - 01/2018
2	Polysaccharides (Glycans)IBA 03/2021 - 06/2005
2	Ion Channels (Ion Channel)IBA 02/2021 - 08/2013
2	myricetinIBA 01/2021 - 01/2018
2	EnzymesIBA 01/2021 - 01/2021
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 01/2020
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2020 - 09/2020
2	Hematoxylin (Haematoxylon)IBA 12/2020 - 09/2020
2	LuteolinIBA 10/2020 - 01/2020
2	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 09/2020 - 06/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2020 - 01/2019
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 07/2020 - 12/2018
2	CholesterolIBA 07/2020 - 06/2002
2	IntegrinsIBA 10/2019 - 03/2019
2	Viral HemagglutininsIBA 01/2019 - 06/2011
2	prostatic acid phosphataseIBA 06/2018 - 01/2015
2	LigandsIBA 01/2018 - 12/2013
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2018 - 01/2018
2	Peptide FragmentsIBA 01/2018 - 10/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018 - 01/2013
2	Immunologic Factors (Immunomodulators)IBA 12/2017 - 09/2012

Therapy/Procedure

30	Therapeutics 01/2022 - 06/2002
5	Immunotherapy 01/2022 - 06/2021
5	Drug Therapy (Chemotherapy) 08/2020 - 01/2004
3	Highly Active Antiretroviral Therapy (HAART) 01/2019 - 05/2011
2	Injections 06/2021 - 01/2019
2	Oral Administration 03/2021 - 01/2021